Glenn Heller

6PUBLICATIONS
52CO-AUTHORS
Predictive and prognostic markersHaematological tumoursMolecular targetsGene and molecular therapy
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (6)

|Dec 01, 2025
Automated Imaging as an Adjunct to Serum and Clinical Biomarkers: A New Validated Prediction Tool for Metastatic Castration-Resistant Prostate Cancer.

Michael J Morris, Jessica Flynn, Binsheng Zhao

|Jan 14, 2025
Measuring the impact of new risk factors within survival models.

Glenn Heller, Sean M Devlin

|Sep 17, 2024
Clonal Hematopoiesis and Clinical Outcomes in Metastatic Castration-Resistant Prostate Cancer Patients Given Androgen Receptor Pathway Inhibitors (Alliance A031201).

Jeffrey L Jensen, Olivia Bobek, Irenaeus C C Chan

|Jun 28, 2024
A Phase I/II Study of Valemetostat (DS-3201b), an EZH1/2 Inhibitor, in Combination with Irinotecan in Patients with Recurrent Small-Cell Lung Cancer.

Noura J Choudhury, W Victoria Lai, Alex Makhnin

|Oct 03, 2022
Inhibition of NF-κB DNA Binding Suppresses Myeloma Growth via Intracellular Redox and Tumor Microenvironment Modulation.

Manpreet Bariana, Elena Cassella, Janice Rateshwar

Pageof 1